FTC settles with CVS drug price allegations
After a two-year investigation, the FTC has settled its deceptive pricing investigation with CVS Caremark Corp. The company will pay $5 million to settle charges that it misrepresented the prices of...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this contentIf you do not currently subscribe to FTCWatch please contact us for subscription information:
Email: customerservices@mlex.com
FTCWatch is delivered in the following formats: via email alert and online at mlexwatch.com/ftcwatch
